| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1540-8191.2006.00210.X |
| P698 | PubMed publication ID | 16492288 |
| P2093 | author name string | James R Sowers | |
| Harold L Lazar | |||
| Rohit Arora | |||
| Jeffrey Probstfield | |||
| Elijah Saunders | |||
| P2860 | cites work | Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP) | Q28181014 |
| Aspirin and mortality from coronary bypass surgery | Q28194029 | ||
| MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial | Q28214393 | ||
| The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES) | Q28374243 | ||
| The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | Q29547887 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
| Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines | Q29619614 | ||
| Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization | Q31804129 | ||
| Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia | Q32076742 | ||
| Statins: effective antiatherosclerotic therapy | Q33876942 | ||
| Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts | Q34131123 | ||
| Two decades of progress in preventing vascular disease | Q34138338 | ||
| A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group | Q34718800 | ||
| Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet | Q35041595 | ||
| Depression and anxiety and outcomes of coronary artery bypass surgery | Q35049215 | ||
| Reporting risks and benefits of therapy by use of the concepts of unqualified success and unmitigated failure: applications to highly cited trials in cardiovascular medicine | Q38547781 | ||
| Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular f | Q40713721 | ||
| Comparison of statins in hypertriglyceridemia | Q41731973 | ||
| Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial | Q43821417 | ||
| Optimism and rehospitalization after coronary artery bypass graft surgery | Q43891686 | ||
| Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI). | Q44213370 | ||
| The effect of obesity on mid-term survival following coronary artery bypass surgery | Q44272443 | ||
| Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting | Q44877942 | ||
| Predictors of chest pain after coronary artery bypass grafting | Q47597161 | ||
| Intensive rehabilitation of emotionally distressed patients after coronary by-pass grafting. | Q51088027 | ||
| Obesity and the risk of early and late mortality after coronary artery bypass graft surgery. | Q52009899 | ||
| Effect of cardiac rehabilitation on functional outcomes after coronary revascularization. | Q53392832 | ||
| Emotional distress before coronary bypass grafting limits the benefits of surgery. | Q53569708 | ||
| The effects of stress management on the quality of life of patients following acute myocardial infarction or coronary bypass surgery. | Q53614364 | ||
| Statement on Exercise: Benefits and Recommendations for Physical Activity Programs for All Americans: A Statement for Health Professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart A | Q56144957 | ||
| Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention | Q56944594 | ||
| Effectiveness of a 24-hour transdermal nicotine patch in conjunction with a cognitive behavioural programme: one year outcome | Q58197021 | ||
| ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary21When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following cita | Q58975824 | ||
| P433 | issue | 2 | |
| P921 | main subject | coronary artery bypass surgery | Q186020 |
| cardiac surgery | Q235007 | ||
| P304 | page(s) | 198-204 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Journal of Cardiac Surgery | Q2044839 |
| P1476 | title | Cardioprotective strategies to improve long-term outcomes following coronary artery bypass surgery | |
| P478 | volume | 21 |
Search more.